Researchers Complete Plans for COVID-19 Vaccine Study for Children in Omaha
OMAHA, Neb. (WOWT) – Right now there is an urge to investigate the effects of the COVID-19 vaccine on children.
In the coming weeks, a local clinic is hoping to start a clinical trial here in Omaha.
The plans are currently being finalized.
Paula Shearer is the mother of two 11 year old boys.
She plans to enroll her sons for the Moderna COVID-19 vaccine study.
“The more my children can participate in a study, the more likely they are to release the vaccines to the pediatric population,” said Paula Shearer.
Quality Clinical Research is working to finalize plans to start the Moderna trial in March.
They hope to have up to 60 children between the ages of 6 months and 12 years enrolled.
A major difference between this study and the adult study?
The dosage will be lower.
Everything else will be very similar to the adult studies.
“It’s a one-on-one placebo study. So a 50/50 chance of getting the real drug or the placebo. And it’s a two-part injection. So you will receive your first injection of either real drug or placebo. We’ll check in every couple of weeks and then I think the second dose is 28 days, just like the adult version, ”said Amanda Kienbaum, Quality Clinical Research.
Details of the study are still being worked on, but according to high quality clinical research, participants are expected to be monitored for up to a year.
Shearer says she’ll be more comfortable knowing the adult version is out.
“It has already been tested on adults. Now all they have to do is test it on children. My children are ridiculously healthy so I think they will be safe to participate in this study, ”Shearer said.
Dr. RR, head of the infectious diseases division at UNMC, says children belong to a special group when it comes to studies.
He says it is important that they be screened to see if the vaccine is safe for this group.
“The barometer is a little different for children. Number one, they are unable to make these complex decisions on their own. That is why we expect their legal guardians, their parents, to make this decision. And because children don’t get seriously ill as often as adults, the safety profile has to be very, very strong, ”said Dr. Mark Rupp, UNMC Head of Infectious Diseases.
Copyright 2021 WOWT. All rights reserved.